BPC-157 Research Information
Body Protection Compound
For Tissue Repair & Regenerative Research
⚠️ Important: This information is for educational and research purposes only. Always consult with a qualified healthcare professional before use.
📑 Contents
🔬 What is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids that is derived from a protective protein naturally found in human gastric juice. It has been the subject of numerous preclinical studies for its remarkable regenerative and cytoprotective properties across multiple tissue types, including muscles, tendons, ligaments, and the gastrointestinal tract.
BPC-157 is available in pen and freeze-dried vial formulations for research purposes.
⚡ How BPC-157 Works
BPC-157 works through multiple pathways to promote healing and tissue repair:
Angiogenesis
Enhances growth hormone receptor expression and pathways involved in new blood vessel formation
Anti-Inflammatory
Reduces inflammatory cytokines while promoting cell growth pathways
Cytoprotection
Promotes mucosal integrity and homeostasis throughout the GI tract
📋 Research Applications
Gastrointestinal Health
Promotes mucosal protection, healing of GI ulcers, IBD, and NSAID-induced injury
Musculoskeletal Repair
Healing of fractures, tendon ruptures, ligament tears, and muscle injuries
Neuroprotection
Counteracts neurotransmitter disturbances and shows beneficial effects in neuropsychiatric conditions
Wound Healing
Promotes healing of various wounds and traumatic injuries
📊 Clinical Studies
Interstitial Cystitis Pilot Study (Lee et al., 2024)
A pilot study involving 12 women with moderate to severe interstitial cystitis who had not responded to pentosan polysulfate. The women received intravesical injections of BPC-157 (total of 10 mg) around the area of inflammation.
- Complete resolution of symptoms after one treatment in 10 of 12 patients (83.3%)
- The remaining 2 patients rated their success at 80%
- No adverse events were reported and no one dropped out
Systematic Review – Orthopedic Sports Medicine (2025)
A systematic review of 36 studies (35 preclinical, 1 clinical) from 1993 to 2024 evaluated BPC-157's effects on musculoskeletal injuries.
- BPC-157 improved functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bony injuries in preclinical models
- In a retrospective study, 7 of 12 patients with chronic knee pain reported relief for >6 months following intraarticular BPC-157 injection
💉 Interactive Dosing Guide
Select your pen size and dose to see the corresponding volume, clicks, dosing frequency, and how many doses per pen:
🖊️ Step 1: Select Your Pen Size
💊 Step 2: Select Your Dose
Pen Size
10mg Pen
Selected Dose
0.25 mg
Doses per Pen
40 doses
Pen Clicks
7.5 clicks
Volume
0.075 mL
Protocol Level
Level 1 (Starting)
Recommended Schedule
1-2 times daily - Loading Phase (Weeks 1-4)
⚠️ Do not change your dose unless advised by a qualified professional.
📋 Protocol Level Summary
Based on research protocols: 200-800 µg/day in 1-2 divided doses.
| Protocol Level | Target Dose | Frequency | Pen Clicks | Who It\'s For |
|---|---|---|---|---|
| Level 1 (Starting) | 0.2-0.25 mg | 1-2x daily | 6-7.5 clicks | New users, first 4 weeks |
| Level 2 (Standard) | 0.5 mg | 1-2x daily | 15 clicks | After 4 weeks, maintenance |
| Level 3 (Advanced) | 0.8 mg | 1-2x daily | 24 clicks | If more response needed |
| Level 4 (Maximum) | 1 mg | 1-2x daily | 30 clicks | Experienced users only |
⚠️ Do not change your dose unless advised by a qualified professional.
💉 Vial Users (Insulin Syringe)
Add 3mL of bacteriostatic water to your freeze-dried vial and mix gently. After reconstitution, use the table below to draw your dose:
Vial Size
10mg vial with 3mL bac water
| Dose | Frequency | Units on Syringe | Volume (mL) | Protocol Level |
|---|
⚠️ Always use a new sterile needle and syringe for each injection.
⚠️ Safety & Precautions
BPC-157 has shown a desirable safety profile in preclinical studies, with only a few side effects reported following its administration. However, no clinical safety data is available in humans.
- Mild irritation at injection sites
- Dizziness or headache (anecdotal)
- Digestive upset when taken orally
Do not use if you:
- Are allergic to BPC-157 or any ingredients
- Are pregnant or breastfeeding
- Are on blood thinners or immunosuppressants (consult a provider first)
⚠️ Warning: BPC-157 is not FDA-approved for human use. If you experience severe allergic reactions, difficulty breathing, or signs of anaphylaxis, seek immediate medical help.
📚 References
- Lee E, Walker C, Ayadi B. Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study. Alternative Therapies in Health and Medicine. 2024;30(10):12.
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. Sage Journals. 2025.
- Vasireddi N, Vasireddi N, Vasireddi SS. Oral Peptide BPC-157—An Emerging Adjunct to Gastrointestinal Therapies? A Systematic Review. American Journal of Gastroenterology. 2025;120(10S2):S174.
- Józwiak M, Bauer M, Kamysz W, Kleczkowska P. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals. 2025;18(2):185.
This information is for educational and research purposes only. Always consult with a qualified healthcare professional.
Last updated: July 2026